These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7509614)

  • 1. [The role of iloprost in the treatment of critical ischemia of the limbs].
    Poggesi L; Comeglio M
    Ann Ital Med Int; 1993 Oct; 8 Suppl():71S-77S. PubMed ID: 7509614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
    Danielsson P; Metzsch C; Norgren L
    Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).
    Meini S; De Franco V; Auteri A; Setacci C; Di Renzo M; Pieragalli D
    Int Angiol; 2005 Mar; 24(1):64-9. PubMed ID: 15877001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iloprost: new indication. Not adequately assessed.
    Prescrire Int; 1999 Apr; 8(40):49-50. PubMed ID: 10848061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
    de Donato G; Gussoni G; de Donato G
    Chir Ital; 2004; 56(6):769-80. PubMed ID: 15771029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.
    Zulian F; Corona F; Gerloni V; Falcini F; Buoncompagni A; Scarazatti M; Martini G; Zacchello F
    Rheumatology (Oxford); 2004 Feb; 43(2):229-33. PubMed ID: 12923288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Our experience in using a synthetic prostacyclin analog in the treatment of critical ischemia of the extremities].
    Centorrino T; Versaci A; Ciccolo A; Terranova ML; Panté S; Barbera A; Cuzzocrea D
    G Chir; 1998 Oct; 19(10):399-403. PubMed ID: 9835185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Randomized placebo-controlled studies of iloprost in treatment of lower limb critical ischaemia].
    Kharazov AF
    Angiol Sosud Khir; 2010; 16(3):27-33. PubMed ID: 21280291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
    Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
    Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P
    Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new infusion method for a prostacyclin analogue].
    Pibiri L; Petruzzo P; Angius D; Ruiu G; Polo F; Rescigno A; Brotzu G
    Minerva Cardioangiol; 1997 Dec; 45(12):621-5. PubMed ID: 9577128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of iloprost in vascular surgery].
    Agrifoglio G; Gabrielli L; Sarcina A; Bonalumi F
    Ann Ital Med Int; 1993 Oct; 8 Suppl():78S-80S. PubMed ID: 7509615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of interaction with the pharmacokinetics of digoxin].
    Cabane J; Penin I; Bouslama K; Benchouieb A; Giral P; Picard O; Wattiaux MJ; Cheymol G; Souvignet G; Imbert JC
    Therapie; 1991; 46(3):235-40. PubMed ID: 1724327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic effects of iloprost in patients with lower limb ischemia.
    Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Soraci S; Bartolone S; Bagnato L; Barbera N
    Panminerva Med; 1997 Sep; 39(3):202-4. PubMed ID: 9360422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma prothrombotic markers after a short- and middle term treatment with iloprost in arteriopathic patients with critical limb ischemia.
    Ferlito S; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli PM; Mazzone D
    Panminerva Med; 1994 Jun; 36(2):76-9. PubMed ID: 7530356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.